| Literature DB >> 28787909 |
Henry U Nwankwo1,2, Collins N Ateba3, Lukman O Olasunkanmi4,5,6, Abolanle S Adekunle7,8,9, David A Isabirye10,11, Damian C Onwudiwe12,13, Eno E Ebenso14,15.
Abstract
The macrocylic ligand, 1,8-dimethyl-1,3,6,8,10,13-hexaazacyclotetradecane (MHACD) was synthesized by the demetallation of its freshly synthesized Ni(II) complex (NiMHACD). Successful synthesis of NiMHACD and the free ligand (MHACD) was confirmed by various characterization techniques, including Fourier transform infra-red (FT-IR), proton nuclear magnetic resonance (¹H-NMR), carbon-13 nuclear magnetic resonance (13C-NMR), ultraviolet-visible (UV-vis), and energy dispersive x-ray (EDX) spectroscopic techniques. The anti-bacteria activities of MHACD were investigated against Staphylococcus aureus and Enterococcus species and the results showed that MHACD possesses a spectrum of activity against the two bacteria. The electrochemical cyclic voltammetry study on MHACD revealed that it is a redox active compound with promising catalytic properties in electrochemical applications. The inhibition potential of MHACD for mild steel corrosion in 1 M HCl was investigated using potentiodynamic polarization method. The results showed that MHACD inhibits steel corrosion as a mixed-type inhibitor, and the inhibition efficiency increases with increasing concentration of MHACD. The adsorption of MHACD obeys the Langmuir adsorption isotherm; it is spontaneous and involves competitive physisorption and chemisorption mechanisms. Quantum chemical calculations revealed that the energy of the highest occupied molecular orbital (HOMO) of MHACD is high enough to favor forward donation of charges to the metal during adsorption and corrosion inhibition. Natural bond orbital (NBO) analysis revealed the presence of various orbitals in the MHACD that are capable of donating or accepting electrons under favorable conditions.Entities:
Keywords: NBO analysis; anticorrosion; antimicrobial; dematallation; electrochemical; macrocycles
Year: 2016 PMID: 28787909 PMCID: PMC5456475 DOI: 10.3390/ma9020107
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Fourier transform infra-red (FT-IR), proton nuclear magnetic resonance (1H-NMR), carbon-13 nuclear magnetic resonance (13C-NMR), ultraviolet-visible (UV-vis), and energy dispersive X-ray (EDX) spectroscopic data for the synthesized NiMHACD and MHACD.
| NiMHACD | |
|---|---|
| FT-IR (v/cm−1) | 1026s (C–N); 1503m (N–H, bend); 3222m (C–H, stretch), 3550b (N–H, stretch) |
| 13C-NMR (CDCl3, δ, ppm) | 39.90 (–N– |
| 1H-NMR (CDCl3, δ, ppm) | 0.9 (s, 6H, –N–C |
| UV-vis (nm) | 214 (1A1g → 1A2g), 324 nm (1A1g → 1B1g) |
| EDX | 22.5% Ni |
| FT-IR (v/cm−1) | 1421s (C–N); 1584m (N–H, bend); 3300b (N–H, stretch) |
| 13C-NMR (CDCl3, δ, ppm ) | 28.56 (–N– |
| 1H-NMR (CDCl3, δ, ppm) | 0.9 (s, 6H, –N–C |
| UV-vis (nm) | 286 (n → σ*) |
| EDX | 0% Ni |
Figure 1The UV-Vis absorption spectra of NiMHACD and MHACD.
Figure 2Antibacterial activities of MHACD against Staphylococcus aureus and Enterococcus species as (a) zone of inhibition against Enterococcus species (A = 4; B = 1; C = 2; D = 3 µg/mL; and the control is the unlabeled white spot at the center of the disc); and (b) variation of inhibition diameter against concentration of MHACD.
Figure 3Cyclic voltammograms for bare Pt electrode in 0.1 M PBS (pH 7.0) without and with 1 mM of MHACD at 25 mV·s−1 scan rate showing the relatively more: (a) cathodic potential region and (b) anodic potential region.
Figure 4Effect of scan rate on the electrochemical behavior of MHACD at ν = 25–300 mV·s−1.
Figure 5Plots of (a) log Ip vs. log ν and (b) Ep vs. log ν for MHACD.
Figure 6Potentiodynamic polarization curves for MS in 1 M HCl without and with various concentrations of the inhibitor (MHACD).
Tafel parameters for MS corrosion in 1 M HCl without and with various concentrations of the inhibitor (L).
| Inhibitor Conc. (ppm) | − | ||||
|---|---|---|---|---|---|
| – | – | Blank (1 M HCl) | – | – | – |
| – | 467 | 2.838 | 134 | 185 | – |
| – | – | Inhibitor (MHACD) | – | – | – |
| 10 | 498 | 2.288 | 153 | 215 | 76.54 |
| 100 | 465 | 1.947 | 128 | 176 | 79.53 |
| 400 | 445 | 1.296 | 90 | 120 | 89.61 |
| 500 | 436 | 1.251 | 90 | 118 | 95.28 |
| 1000 | 464 | 0.581 | 86 | 129 | 98.58 |
Figure 7Langmuir adsorption isotherm for MS in 1 M HCl containing various concentrations of MHACD at 303 K. The values of Kads and ΔGads are listed on the graph.
Figure 8Optimized structure (a); the highest occupied molecular orbital (HOMO) (b); and and lowest unoccupied molecular orbital (LUMO) (c) of MHACD. Only the non-hydrogen atoms are shown and numbered in the optimized structure such that: grey = Carbon; blue = Nitrogen. The numbering pattern in the optimized structure is used for discussion of the results.
Selected bond lengths in the optimized structure of MHACD.
| Geometry Parameter | Gas Phase |
|---|---|
| C1–N5 | 1.458 |
| C6–N5 | 1.466 |
| C6–N12 | 1.455 |
| C9–N5 | 1.465 |
| C9–N14 | 1.449 |
| C16–N12 | 1.456 |
| C19–N14 | 1.465 |
| C16–C22 | 1.533 |
| C19–C25 | 1.530 |
| C22–N28 | 1.452 |
| C25–N30 | 1.462 |
| C32–N28 | 1.446 |
| C35–N30 | 1.455 |
| C32–N38 | 1.460 |
| C35–N38 | 1.476 |
| C39–N38 | 1.458 |
Some quantum chemical parameters of the synthesized ligand (MHACD).
| Quantum Chemical Parameters | ||||||
|---|---|---|---|---|---|---|
| EHOMO (eV) | ELUMO (eV) | ∆E (eV) | χ (eV) | η (eV) | ∆N | Dipole Moment (Debye) |
| −4.17 | 0.11 | 4.27 | 2.03 | 2.14 | 1.16 | 1.74 |
Natural bond orbital (NBO) analysis of the N atoms in the molecule of MHACD.
| Atom | Orbital Type | Occupancy | Energy (a.u) |
|---|---|---|---|
| N5 | 2s | 1.283 | −0.517 |
| 2px | 1.576 | −0.203 | |
| 2py | 1.26 | −0.187 | |
| 2pz | 1.435 | −0.195 | |
| N12 | 2s | 1.339 | −0.523 |
| 2px | 1.365 | −0.179 | |
| 2py | 1.639 | −0.193 | |
| 2pz | 1.35 | −0.177 | |
| N14 | 2s | 1.334 | −0.525 |
| 2px | 1.249 | −0.171 | |
| 2py | 1.543 | −0.189 | |
| 2pz | 1.575 | −0.197 | |
| N28 | 2s | 1.333 | −0.521 |
| 2px | 1.285 | −0.174 | |
| 2py | 1.502 | −0.188 | |
| 2pz | 1.59 | −0.193 | |
| N30 | 2s | 1.32 | −0.514 |
| 2px | 1.265 | −0.168 | |
| 2py | 1.563 | −0.184 | |
| 2pz | 1.561 | −0.188 | |
| N38 | 2s | 1.291 | −0.513 |
| 2px | 1.263 | −0.182 | |
| 2py | 1.256 | −0.181 | |
| 2pz | 1.728 | −0.204 |
Rydberg orbitals of C and N atoms in the molecule of MHACD.
| Atom | Orbital Type | Energy (a.u) |
|---|---|---|
| C1 | 3dxy | 2.164 |
| C6 | 3dxz | 2.206 |
| C9 | 3dxy | 2.180 |
| C16 | 3dxz | 2.133 |
| C19 | 3dz2 | 2.077 |
| C25 | 3dz2 | 2.092 |
| C35 | 3dx2 − y2 | 2.209 |
| C39 | 3dxz | 2.239 |
| N5 | 3dxy | 2.122 |
| N12 | 3dxy | 2.190 |
| N14 | 3dz2 | 2.103 |
| N28 | 3dxz | 2.179 |
| N30 | 3dz2 | 2.098 |
| N38 | 3dxz | 2.094 |
Figure 9Synthesis of (NiMHACD).
Figure 10Demetallation of NiMHACD to obtain the metal-free ligand, MHACD.